Highest R&D Intensity
Companies ranked by R&D spending as a percentage of revenue, indicating focus on innovation and future growth. Top 50 S&P 500 companies ranked by r&d intensity.
Top 50 by R&D Intensity
| # | Company | Sector | R&D Intensity |
|---|---|---|---|
| 1 | BNGOBionano Genomics, Inc. | - | 39.9% |
| 2 | VNDAVanda Pharmaceuticals Inc. | - | 39.9% |
| 3 | INCYIncyte | Health Care | 39.9% |
| 4 | DSNYDESTINY MEDIA TECHNOLOGIES INC | - | 39.1% |
| 5 | CRNCCerence Inc. | - | 38.8% |
| 6 | AQSTAquestive Therapeutics, Inc. | - | 38.6% |
| 7 | OUSTOuster, Inc. | Industrials | 38.5% |
| 8 | AMPGAmpliTech Group, Inc. | - | 37.8% |
| 9 | CLPTClearPoint Neuro, Inc. | - | 37.6% |
| 10 | DCTHDELCATH SYSTEMS, INC. | - | 37.3% |
| 11 | CSAICLOUDASTRUCTURE, INC. | - | 37.2% |
| 12 | BFLYButterfly Network, Inc. | Health Care | 37.1% |
| 13 | TXG10x Genomics, Inc. | Health Care | 37.1% |
| 14 | GHGuardant Health, Inc. | Health Care | 37.1% |
| 15 | HTFLHeartflow, Inc. | Health Care | 36.9% |
| 16 | VYGRVoyager Therapeutics, Inc. | - | 36.9% |
| 17 | NUWENuwellis, Inc. | - | 36.7% |
| 18 | FROGJFrog Ltd | Information Technology | 36.7% |
| 19 | SITMSiTime | Information Technology | 36.4% |
| 20 | STXSStereotaxis, Inc. | - | 36.3% |
| 21 | LAWCS Disco, Inc. | - | 36.1% |
| 22 | LSCCLattice Semiconductor | Information Technology | 35.9% |
| 23 | MIRMMirum Pharmaceuticals, Inc. | Health Care | 35.7% |
| 24 | ALABAstera Labs, Inc. | Information Technology | 35.7% |
| 25 | EXELExelixis | Health Care | 35.6% |
| 26 | RDDTReddit, Inc. | Information Technology | 35.6% |
| 27 | ALNYALNYLAM PHARMACEUTICALS, INC. | Health Care | 35.5% |
| 28 | FEEDENvue Medical, Inc. | - | 35.5% |
| 29 | NBIXNeurocrine Biosciences | Health Care | 35.5% |
| 30 | SNPSSynopsys | Information Technology | 35.1% |
| 31 | SSentinelOne, Inc. | Information Technology | 35.1% |
| 32 | TBPHTheravance Biopharma, Inc. | Health Care | 34.8% |
| 33 | SVCOSilvaco Group, Inc. | - | 34.8% |
| 34 | BBNXBeta Bionics, Inc. | Health Care | 34.7% |
| 35 | GTLBGitlab Inc. | Information Technology | 34.6% |
| 36 | MRVLMarvell Technology, Inc. | Information Technology | 34.4% |
| 37 | NVCRNovoCure Ltd | Health Care | 34.3% |
| 38 | VANIVivani Medical, Inc. | - | 33.9% |
| 39 | ADPTAdaptive Biotechnologies Corp | Health Care | 33.9% |
| 40 | PINSPinterest | - | 33.8% |
| 41 | CORTCorcept Therapeutics Incorporated | Health Care | 33.5% |
| 42 | TTANServiceTitan, Inc. | Information Technology | 33.1% |
| 43 | GEVOGevo, Inc. | - | 33.0% |
| 44 | NAVNNavan, Inc. | Information Technology | 32.9% |
| 45 | RBRKRubrik, Inc. | Information Technology | 32.9% |
| 46 | RXSTRxSight, Inc. | - | 32.6% |
| 47 | VRTXVertex Pharmaceuticals | Health Care | 32.6% |
| 48 | PDPagerDuty, Inc. | Information Technology | 32.5% |
| 49 | IRWDIRONWOOD PHARMACEUTICALS INC | Health Care | 32.1% |
| 50 | RBLXRoblox Corp | Information Technology | 32.1% |
Understanding R&D Intensity
R&D intensity measures how much a company invests in research and development relative to its revenue. Higher R&D intensity often indicates a focus on innovation and long-term competitive advantage. Tech companies like Intel and Qualcomm typically have 15-25% R&D intensity, while pharmaceutical companies invest 10-20%.
Rankings are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from this ranking.
Related Rankings
By Sector
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology